Andrew joined CBRE in 2015 with over 12 years of experience in exclusively representing corporate tenants on a global, national and regional basis. He provides an all-encompassing strategic approach to his clients' real estate needs. By implementing innovative, cost-cutting strategies while providing needed flexibility for future business initiatives, Andrew ensures that his clients' occupancy solutions meet both their short-term and long-term operational needs.
Andrew's areas of expertise include corporate real estate portfolio optimization, corporate lease acquisitions, lease restructuring, purchase acquisition, excess real estate disposition, creative finance strategies, municipal incentives, labor analytics and overall real estate implications on the corporate balance sheet.
Throughout his career, Andrew has represented a myriad of companies across a variety of industries in fulfilling their office, industrial and R&D requirements. In the Life Sciences, Medical Device and Biotechnology sectors, some of Andrew's clients include Alere, Pacira Pharmaceuticals, Vertex Pharmaceuticals, Ameditech, Suneva Medical and Ambit Biosciences.